HALOPERIDOL DECANOATE INJECTION, 50 mg/mL, 1 mL vial, Rx only, Fresenius Kabi USA, LLC, Schaumburg, IL 60173 NDC 63323-469-01
Published November 19, 2014 · Recall initiated: April 14, 2014
Summary
FDA records drug Class III recall D-0247-2015, published November 19, 2014 and initiated April 14, 2014. Recalling firm: Fresenius Kabi USA LLC; Status: Terminated; Reported quantity: 216,517 vials; Lot: Lot 6105149, Exp.05/14; 6105696, Exp. 07/14; 6105836, Exp. 08/14; Lot 6106516, Exp. 12/14; Lot 6106837, Exp. 02/15. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specifications: Fresenius Kabi is recalling three lots of Haloperidol Decanoate Injection due to an out-of-specification result.
What to do
Voluntary: Firm initiated · Letter
Get an email if HALOPERIDOL DECANOATE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- HALOPERIDOL DECANOATE
- Manufacturer
- Fresenius Kabi USA LLC
- Distributor
- Nationwide and Puerto Rico
- Lot
- Lot 6105149, Exp.05/14; 6105696, Exp. 07/14; 6105836, Exp. 08/14; Lot 6106516, Exp. 12/14; Lot 6106837, Exp. 02/15
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAHaloperidol Decanoate Injection, 100 mg/mL*, 1 x 1 mL Single-Dose Vial, Rx only, Manufactured by: SomersetApril 30, 2025
- FDAHaloperidol Decanoate Injection, 100mg/mL*, 5 x 1 mL Single-Dose Vials, Rx Only, Manufactured by: SomersetApril 30, 2025
- FDAHaloperidol Decanoate Injection, 50mg/mL* , 1 mL Single-Dose Vial, Rx only, Manufactured by SomersetApril 30, 2025
- FDAHaloperidol Decanoate Injection 50mg/mL, 1mL Single-Dose Vial, Rx Only, Manufactured by: Somerset TherapeuticsApril 16, 2025
- FDASimvastatin Tablets, USP, 10 mg, Rx Only, 90 count bottles, Manufactured by: Micro Labs Limited, Goa-403 722,November 19, 2014
- FDAAssured Naproxen Sodium Tablets, USP 220 mg., 15 count bottle, Repackaged by Contract Packaging Resources, IncNovember 19, 2014
Questions about this recall
Was HALOPERIDOL DECANOATE INJECTION, 50 mg/mL, 1 mL vial, Rx only, Fresenius Kabi USA, LLC, Schaumburg, IL 60173 NDC 63323-469-01 recalled?
Yes. FDA published recall D-0247-2015 on November 19, 2014. Reported hazard: Failed Impurities/Degradation Specifications: Fresenius Kabi is recalling three lots of Haloperidol Decanoate Injection due to an out-of-specification result.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: HALOPERIDOL DECANOATE.